Jefferies & Company
JEF
$51.96
-3.65%
Jefferies Financial Group Inc. is a full-service investment banking and capital markets firm, offering advisory, underwriting, and trading services primarily to the North American middle market. The company has evolved from a trading-focused institution into a top-tier independent investment bank, leveraging its 2013 merger with Leucadia to expand its balance sheet and market share. Currently, the stock is under scrutiny as it navigates a volatile market environment, with recent price swings reflecting investor concerns about deal flow, interest rates, and the broader economic outlook, despite a strong rebound in the first half of 2026.…
JEF
Jefferies & Company
$51.96
Related headlines
Investment Opinion: Should I buy JEF Today?
Rating: Buy. Jefferies offers a compelling risk-reward at current levels, with a forward PE of 12.16x and an average analyst target of $61.50, implying 11.4% upside. The stock's strong revenue growth of 36.7% YoY and improving profitability support a positive outlook, while the discounted valuation relative to peers provides a margin of safety.
Sign up to view all
JEF 12-Month Price Forecast
The AI model assesses Jefferies as a bullish opportunity, driven by its robust revenue acceleration, attractive forward valuation, and solid cash flow generation. The medium confidence reflects the cyclical nature of the business and the mixed analyst sentiment. The stock's recovery from its 52-week low and the potential for continued earnings growth support a positive outlook. However, the model would downgrade its stance if revenue growth decelerates below 15% or if the debt-to-equity ratio rises significantly, indicating increased financial risk.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Jefferies & Company's 12-month outlook, with a consensus price target around $60.67 and implied upside of +16.8% versus the current price.
Average Target
$60.67
0 analysts
Implied Upside
+16.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$46 - $83
Analyst target range
Analyst coverage is limited, with only 6 analysts providing targets, and the consensus recommendation is 'none' due to a mix of ratings. The average target price is $61.50, implying an 11.4% upside from the current price of $55.23. The target range is wide, from $46.00 to $83.00, indicating high uncertainty. The low target suggests a potential 16.7% downside, possibly reflecting concerns about market volatility or a downturn in investment banking. The high target implies a 50.3% upside, likely assuming a strong recovery in M&A and capital markets activity. Recent ratings have been mixed, with UBS downgrading from Buy to Neutral in June 2026, while Oppenheimer and Goldman Sachs maintain Outperform and Buy ratings, respectively. The wide spread and limited coverage suggest that Jefferies may be under-followed, leading to potential inefficiencies in price discovery.
Bulls vs Bears: JEF Investment Factors
Jefferies presents a compelling recovery story, with robust revenue growth and improving profitability, yet it remains burdened by high leverage and a history of underperformance relative to the market. The bull case is supported by strong Q2 results, attractive forward valuation, and solid cash flow, while the bear case hinges on cyclical risks, mixed analyst sentiment, and the potential for a market downturn. Currently, the evidence slightly favors the bull side, given the clear acceleration in earnings and the discounted forward PE. The most critical tension is whether the recent rebound in investment banking activity is sustainable or merely a temporary upswing that could reverse with a market correction.
Bullish
- Strong Revenue Acceleration: Q2 2026 revenue surged 36.74% YoY to $3.41B, with sequential growth from $2.87B in Q1, signaling robust demand for investment banking and trading services. This marks a clear inflection from the prior year's stagnation.
- Attractive Forward Valuation: Forward PE of 12.16x implies an earnings yield of 8.2%, a 19% discount to the industry average forward PE of 15x. This suggests the market is pricing in substantial earnings growth, yet the stock remains reasonably valued.
- Strong Free Cash Flow Generation: TTM free cash flow stands at $1.78B, with Q2 operating cash flow of $1.60B, providing ample liquidity for dividends and buybacks. The current dividend yield of 3.05% is supported by a payout ratio of 52.7%.
- Rebound from 52-Week Low: The stock has rallied 55.4% from its 52-week low of $35.53 to $55.23, yet remains 22% below its 52-week high of $71.04, indicating potential for further upside if momentum persists. The 6-month gain of 44.2% underscores a strong recovery trend.
Bearish
- High Debt-to-Equity Ratio: Debt-to-equity of 2.25x is elevated, though typical for financial institutions, it amplifies vulnerability to rising interest rates and credit market stress. Interest expense of $911.7M in Q2 consumed a significant portion of operating income.
- Underperformance vs. Market: The stock is down 15.0% over the past year, while the S&P 500 gained 18.7%, resulting in a relative strength of -33.6%. This persistent underperformance may reflect structural challenges or investor skepticism.
- Mixed Analyst Sentiment: Only 6 analysts cover the stock, with a consensus recommendation of 'none' due to mixed ratings. UBS downgraded to Neutral in June 2026, while the wide target range of $46-$83 signals high uncertainty about future performance.
- Volatile Earnings History: Net margin has fluctuated significantly, from 3.97% in Q2 2025 to 7.49% in Q2 2026, with operating margin dropping from 41.4% in Q1 to 35.7% in Q2. This volatility complicates earnings predictability and valuation.
JEF Technical Analysis
Jefferies' stock has experienced a volatile year, with a 1-year price change of -14.99%, yet it has rebounded strongly from its 52-week low of $35.53 to a current price of $55.23, placing it at 78% of its 52-week range (between the low and high of $71.04). This positioning suggests the stock is recovering from a significant drawdown but remains well below its highs, indicating potential for further upside if momentum continues. The 6-month price change of +44.24% highlights a strong recovery trend, though the stock is still down from its peak, reflecting lingering market skepticism.
Beta
—
—
Max Drawdown
-48.8%
Largest decline past year
52-Week Range
$36-$71
Price range past year
Annual Return
-22.7%
Cumulative gain past year
| Period | JEF Return | S&P 500 |
|---|---|---|
| 1m | -5.2% | -1.1% |
| 3m | -15.7% | +3.0% |
| 6m | +42.9% | +15.4% |
| 1y | -22.7% | +16.2% |
| ytd | -18.1% | +12.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
JEF Fundamental Analysis
Jefferies' revenue has shown robust growth, with the most recent quarter (Q2 2026) reporting revenue of $3.41 billion, a 36.74% year-over-year increase. This growth is driven by strong investment banking revenue of $1.21 billion and principal transactions revenue of $488.67 million, while interest revenue contributed $853.96 million. The multi-quarter trend shows acceleration, with Q1 2026 revenue of $2.87 billion and Q4 2025 revenue of $2.95 billion, indicating a rebound from earlier stagnation. The company's net income for Q2 2026 was $255.42 million, with a net margin of 7.49%, and gross margin improved to 91.2%, reflecting strong operational leverage. However, operating margin was 35.69% in Q2, down from 41.38% in Q1, suggesting some cost pressures. Jefferies maintains a solid balance sheet with a current ratio of 2.43 and debt-to-equity of 2.25, though its high leverage is typical for financial institutions. Free cash flow for the trailing twelve months was $1.78 billion, and the company generated $1.60 billion in operating cash flow in Q2 2026, providing ample liquidity for dividends and buybacks.
Quarterly Revenue
$3.4B
2026-05
Revenue YoY Growth
+36.7%
YoY Comparison
Gross Margin
91.2%
Latest Quarter
Free Cash Flow
$1.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is JEF Overvalued?
Given that Jefferies is profitable, the PE ratio is the primary valuation metric. The trailing PE is 19.43x, while the forward PE is 12.16x, indicating the market expects significant earnings growth. The gap between trailing and forward PE suggests a forward earnings yield of 8.2%, which is attractive for a financial firm. Compared to the industry average PE of 15x (based on historical data), Jefferies trades at a 29.5% premium on a trailing basis, but on a forward basis, it trades at a 19% discount, reflecting optimism about future earnings. Historically, Jefferies' PE has ranged from 5.7x to 150x over the past five years, with the current trailing PE near the lower end of that range, suggesting the stock is undervalued relative to its own history. The PB ratio of 1.16x is also below the historical average of 1.2x, further supporting a value proposition.
PE
19.4x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 6x~31x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
20.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financially, Jefferies carries a high debt-to-equity ratio of 2.25x, which, while typical for financial institutions, exposes it to interest rate fluctuations and credit market stress. Interest expense of $911.7M in Q2 2026 represents a substantial fixed cost, and any rise in borrowing costs could compress margins. The company's net margin of 7.49% is relatively thin, leaving limited room for error if revenues decline. Additionally, the payout ratio of 52.7% indicates that a significant portion of earnings is returned to shareholders, potentially limiting reinvestment in growth opportunities during downturns.
FAQ
The primary risks include: 1) Financial risk from high leverage (debt-to-equity of 2.25x), which could amplify losses in a downturn. 2) Market risk from cyclicality in investment banking, as a slowdown in M&A or trading could sharply reduce revenue. 3) Competitive risk from larger, more diversified banks that may gain market share. 4) Macro risk from rising interest rates, which increase borrowing costs and reduce deal activity. The stock's beta and max drawdown of -48.8% highlight its sensitivity to market conditions. Investors should monitor these factors closely.
The 12-month forecast is moderately bullish, with a base case target of $61.50 (11.4% upside) and a bull case target of $83 (50.3% upside), while the bear case target is $46 (16.7% downside). The base case, with a 50% probability, assumes continued revenue growth and stable margins. The bull case, at 30% probability, requires a strong recovery in capital markets, while the bear case, at 20% probability, involves an economic downturn. The most likely scenario is the base case, driven by the current momentum in investment banking activity.
On a trailing basis, JEF trades at a PE of 19.43x, a 29.5% premium to the industry average of 15x, but this is misleading due to depressed earnings. On a forward basis, the PE is 12.16x, a 19% discount to the industry, indicating the market expects significant earnings growth. The stock's PB ratio of 1.16x is below its historical average of 1.2x, and its forward earnings yield of 8.2% is attractive. Overall, JEF appears undervalued relative to its growth prospects and historical valuation, suggesting the market is pricing in a recovery that is not yet fully reflected in earnings.
Jefferies offers a favorable risk-reward profile, with a forward PE of 12.16x and an average analyst target of $61.50, implying 11.4% upside. The stock has shown strong momentum, with a 44.2% gain over the past six months, and its revenue growth of 36.7% YoY indicates a robust recovery. However, the high debt-to-equity ratio and cyclicality of investment banking make it a higher-risk investment. It could be a good buy for investors who believe the recovery in capital markets is sustainable and are willing to tolerate volatility. For more conservative investors, waiting for a pullback or a clearer trend in M&A activity might be prudent.
JEF is more suitable for medium-to-long-term investment, given its cyclical nature and the time required for earnings to fully recover. The stock's beta and volatility make it less ideal for short-term trading, though its recent momentum could offer opportunities. The dividend yield of 3.05% provides some income cushion for long-term holders. A minimum holding period of 2-3 years is recommended to ride out market cycles and capture the full benefit of the recovery. Investors with a shorter horizon should be prepared for significant price swings.